SignatureFD’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.83M | Buy |
31,988
+1,298
| +4% | +$290K | 0.1% | 72 |
|
|
2025
Q4 | $5.25M | Sell |
30,690
-291
| -0.9% | -$45.3K | 0.08% | 89 |
|
|
2025
Q3 | $4.15M | Buy |
30,981
+1,778
| +6% | +$188K | 0.07% | 107 |
|
|
2025
Q2 | $2.84M | Sell |
29,203
-3,185
| -10% | -$253K | 0.05% | 155 |
|
|
2025
Q1 | $2.35M | Sell |
32,388
-718
| -2% | -$56.5K | 0.04% | 160 |
|
|
2024
Q4 | $2.39M | Buy |
33,106
+1,276
| +4% | +$96.8K | 0.05% | 153 |
|
|
2024
Q3 | $2.6M | Sell |
31,830
-1,010
| -3% | -$87.8K | 0.05% | 138 |
|
|
2024
Q2 | $3.5M | Buy |
32,840
+220
| +0.7% | +$21.1K | 0.07% | 97 |
|
|
2024
Q1 | $3.17M | Buy |
32,620
+8,110
| +33% | +$713K | 0.07% | 106 |
|
|
2023
Q4 | $1.92M | Buy |
24,510
+1,220
| +5% | +$83.1K | 0.04% | 160 |
|
|
2023
Q3 | $1.46M | Sell |
23,290
-650
| -3% | -$42.7K | 0.04% | 182 |
|
|
2023
Q2 | $1.54M | Buy |
23,940
+2,410
| +11% | +$136K | 0.04% | 169 |
|
|
2023
Q1 | $1.14M | Buy |
21,530
+240
| +1% | +$11.8K | 0.03% | 217 |
|
|
2022
Q4 | $895K | Sell |
21,290
-1,680
| -7% | -$70.3K | 0.03% | 254 |
|
|
2022
Q3 | $841K | Buy |
22,970
+910
| +4% | +$40.5K | 0.03% | 227 |
|
|
2022
Q2 | $940K | Buy |
22,060
+4,880
| +28% | +$232K | 0.03% | 202 |
|
|
2022
Q1 | $924K | Sell |
17,180
-1,960
| -10% | -$114K | 0.03% | 232 |
|
|
2021
Q4 | $1.38M | Sell |
19,140
-920
| -5% | -$57.7K | 0.04% | 154 |
|
|
2021
Q3 | $1.14M | Buy |
20,060
+980
| +5% | +$59.6K | 0.04% | 172 |
|
|
2021
Q2 | $1.24M | Buy |
19,080
+1,500
| +9% | +$94.7K | 0.05% | 150 |
|
|
2021
Q1 | $1.05M | Buy |
17,580
+1,560
| +10% | +$85K | 0.05% | 154 |
|
|
2020
Q4 | $757K | Sell |
16,020
-290
| -2% | -$12.2K | 0.04% | 185 |
|
|
2020
Q3 | $541K | Sell |
16,310
-230
| -1% | -$7.92K | 0.03% | 223 |
|
|
2020
Q2 | $535K | Buy |
16,540
+720
| +5% | +$19.6K | 0.03% | 209 |
|
|
2020
Q1 | $380K | Buy |
15,820
+1,780
| +13% | +$51.3K | 0.03% | 243 |
|
|
2019
Q4 | $411K | Buy |
14,040
+1,480
| +12% | +$39.3K | 0.03% | 278 |
|
|
2019
Q3 | $290K | Buy |
12,560
+300
| +2% | +$6.3K | 0.02% | 318 |
|
|
2019
Q2 | $230K | Buy |
12,260
+730
| +6% | +$13.8K | 0.02% | 348 |
|
|
2019
Q1 | $206K | Buy |
11,530
+460
| +4% | +$7.67K | 0.02% | 384 |
|
|
2018
Q4 | $151K | Sell |
11,070
-1,330
| -11% | -$19.1K | 0.01% | 447 |
|
|
2018
Q3 | $188K | Sell |
12,400
-210
| -2% | -$3.59K | 0.02% | 436 |
|
|
2018
Q2 | $218K | Buy |
12,610
+3,500
| +38% | +$67.4K | 0.02% | 384 |
|
|
2018
Q1 | $185K | Buy |
+9,110
| New | +$180K | 0.02% | 359 |
|
|
2016
Q4 | – | Sell |
-5,070
| Closed | -$48K | – | 792 |
|
|
2016
Q3 | $48K | Sell |
5,070
-510
| -9% | -$4.64K | 0.01% | 541 |
|
|
2016
Q2 | $47K | Sell |
5,580
-400
| -7% | -$3.21K | 0.01% | 493 |
|
|
2016
Q1 | $49K | Buy |
5,980
+1,350
| +29% | +$9.82K | 0.01% | 433 |
|
|
2015
Q4 | $37K | Buy |
4,630
+2,930
| +172% | +$22K | 0.01% | 420 |
|
|
2015
Q3 | $11K | Sell |
1,700
-730
| -30% | -$5.35K | ﹤0.01% | 666 |
|
|
2015
Q2 | $20K | Buy |
2,430
+730
| +43% | +$5.73K | ﹤0.01% | 472 |
|
|
2015
Q1 | $12K | Buy |
+1,700
| New | +$13.4K | ﹤0.01% | 506 |
|
Other funds holding LRCX
VCM
VPM
SignatureFD's LRCX Position: Q1 2026 in Review
SignatureFD increased its Lam Research (LRCX) stake by 4.2% in Q1 2026, buying an estimated $290K and bringing the position to 31,988 shares worth $6.83M. The position accounts for 0.1% of the portfolio, ranked #72.
SignatureFD first reported a position in LRCX in Q1 2015 and has held it in 40 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.
- SignatureFD held 31,988 shares of Lam Research worth $6.83M as of Q1 2026.
- SignatureFD bought 1,298 Lam Research shares in Q1 2026, an estimated $290K.
- Lam Research made up 0.1% of SignatureFD's portfolio in Q1 2026, its #72 holding.
- SignatureFD first reported a position in Lam Research in Q1 2015 and has held it in 40 quarters since.
- 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.